Longevity is a scorching development in Silicon Valley nowadays, pushed by rising curiosity—particularly among the many rich—in stopping illness via common testing.
A brand new participant, Biograph, has simply emerged from stealth, and it’s co-founded by one of many largest names in longevity science: Dr. Peter Attia. Attia is a Canadian-American doctor greatest generally known as the writer of the bestseller “Outlive: The Science and Artwork of Longevity” and for his podcast.
Biograph’s CEO and different co-founder is John Hering, a distinguished Silicon Valley determine. A cybersecurity founder who infamously scanned celebrities’ cellphones on the 2005 Academy Awards, Hering has develop into greatest generally known as one Elon Musk’s largest backers via his function as a accomplice at Vy Capital. There, Hering has poured billions into Musk’s startups and donated $500,000 to a pro-Trump tremendous PAC earlier than the election, per a WSJ profile.
Biograph calls itself the world’s “most superior” preventive well being and diagnostics clinic. It at present has a location in Silicon Valley with plans to open in New York Metropolis this quarter, and finally increase globally, in accordance to an announcement on its website.
The startup says it should acquire over 1,000 information factors throughout 30+ evaluations to color a holistic image of somebody’s well being and optimize their lifespan. It doesn’t come low-cost: its Core membership prices $7,500 per yr whereas the premium Black membership—which it says supplies the “deepest insights”—runs $15,000.
Biograph is backed by Vy Capital, Human Capital, Alpha Wave, and Wndr Co, together with angel traders together with Balaji Srinivasan, the startup advised TechCrunch. Biograph declined to specify how a lot funding it has raised.
In a statement, Hering mentioned he was impressed to co-found Biograph by the most cancers prognosis of his Vy Capital accomplice and good friend Alexander Tamas. Tamas posted on X {that a} check-up in his late 30s resulted in an early thyroid most cancers prognosis that in all probability saved his life—and prompted him to encourage Hering to get checked, too.
Biograph claims that over 15% of members have reported discovering “pressing or life-alerting well being” insights via its providers. The corporate has been quietly working since 2020, in line with the LinkedIn profile of its government medical director Michael Doney, a physician with a background in longevity.
Whereas Biograph’s announcement doesn’t point out AI, the corporate is at present on the lookout for a founding AI engineer to construct an AI-powered assistant, in line with its careers web page.
Biograph is a part of a quiet growth in startups devoted to residing longer, with Andreessen Horowitz-backed Perform Well being seeking a $2 billion valuation this yr and Sam Altman-backed Retro Biosciences in talks to raise a cool $1 billion final month.
About The Author
